Mothe Andrea J, Tator Charles H
Krembil Neuroscience Centre, Toronto Western Research Institute and Toronto Western Hospital, University Health Network and University of Toronto, 399 Bathurst Street, Toronto, ON, Canada M5T 2S8.
Int J Dev Neurosci. 2013 Nov;31(7):701-13. doi: 10.1016/j.ijdevneu.2013.07.004. Epub 2013 Aug 6.
Spinal cord injury (SCI) is a debilitating condition often resulting in paralysis, yet currently there is no effective treatment. Stem cell transplantation is a promising therapeutic strategy for promoting tissue repair after SCI. Stem cells offer a renewable source of cells with inherent plasticity for tissue regeneration. Neural stem/progenitor cells (NSPCs) are multipotent cells that self-renew and are committed to the neural lineage, and thus, they are especially suited to SCI repair. NSPCs may differentiate into neural cells after transplantation into the injured spinal cord, replacing lost or damaged cells, providing trophic support, restoring connectivity, and facilitating regeneration. Here, we review experimental studies and considerations for clinical translation of NSPC transplantation for SCI.
脊髓损伤(SCI)是一种使人衰弱的病症,常常导致瘫痪,但目前尚无有效的治疗方法。干细胞移植是促进脊髓损伤后组织修复的一种有前景的治疗策略。干细胞为组织再生提供了具有内在可塑性的可再生细胞来源。神经干/祖细胞(NSPCs)是多能细胞,能够自我更新并定向分化为神经谱系细胞,因此,它们特别适合用于脊髓损伤修复。将NSPCs移植到受损脊髓后,它们可能会分化为神经细胞,替代丢失或受损的细胞,提供营养支持,恢复连接,并促进再生。在此,我们综述了关于NSPCs移植用于脊髓损伤临床转化的实验研究及相关考量。